Compound Xuanju capsules combined with phosphodiesterase-5 inhibitors as a new strategy for erectile dysfunction: a meta-analysis and trial sequential analysis

QR Code

Compound Xuanju capsules combined with phosphodiesterase-5 inhibitors as a new strategy for erectile dysfunction: a meta-analysis and trial sequential analysis

ObjectiveThe efficacy of compound Xuanju capsule (CXC) in the treatment of erectile dysfunction (ED) remains unclear. This study aimed to quantitatively assess the benefits and risks of CXC in the treatment of ED.MethodsEight major databases were systematically searched for relevant literature publi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ronghui Li, Min Liao, Yunfeng Yu, Bing Guo, Rong Yu, Qinghu He, Guomin Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Pharmacology
Subjects:	compound Xuanju capsule phosphodiesterase type 5 inhibitor erectile dysfunction meta-analysis trial sequential analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1537789/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
by: M. N. Mamedov, et al.
Published: (2016-01-01)

A review of phosphodiesterase type 5 inhibitors
by: N. Schellack, et al.
Published: (2014-05-01)

The choice of the medicine phosphodiesterase inhibitors of 5th type for treating patients with erectile dysfunction and chronic prostatitis
by: P. V. Glybochko, et al.
Published: (2013-06-01)

Sequential methods in statistics /
by: Wetherill, G. Barrie
Published: (1986)

Effect of phosphodiesterase inhibitors on platelet function
by: Ravi Hochuli, et al.
Published: (2025-09-01)

PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
by: A. A. Kamalov, et al.
Published: (2018-03-01)

Erectile function rehabilitation with phosphodiesterase type 5 inhibitors in patients following nerve-sparing radical prostatectomy: a comparative efficacy analysis of different course lengths
by: E. V. Pomeshkin, et al.
Published: (2025-03-01)

Use of phosphodiesterase 4 inhibitor in patients with psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2017-04-01)

Analyzing food supplements to enhance erectile system function for the presence of undeclared sildenafil and tadalafil using HPLC-DAD
by: Bozhinoska Zorica, et al.
Published: (2025-01-01)

Psychogenic Erectile Dysfunction: A Multidisciplinary Problem
by: A. O. Vasiliev, et al.
Published: (2023-10-01)

The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2018-04-01)

MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS
by: G. G. Sharvadze, et al.
Published: (2018-06-01)

Surgical methods for the correction of erectile dysfunction
by: P. S. Kyzlasov, et al.
Published: (2022-05-01)

Combined bailing capsule and conventional therapies in the treatment of chronic renal failure: a meta-analysis and economic evaluation
by: Yumei He, et al.
Published: (2025-06-01)

Low-Intensity Extracorporeal Shockwave Therapy – A New Approach in the Treatment of Erectile Dysfunction after Radical Prostatectomy
by: Boyan Stoykov, et al.
Published: (2018-03-01)

ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 1 DIABETES: DIAGNOSIS AND TREATMENT METHODS
by: D. G. Kurbatov, et al.
Published: (2014-06-01)

A Multi-Branch-Based Capsule Network With Structural Reparameterization
by: Kun Sun, et al.
Published: (2025-01-01)

Erectile dysfunction
by: Haley Smith
Published: (2015-03-01)

Clinical outcomes and safety of 7-day versus 14-day antibiotic therapy for bloodstream infections in adults: A systematic review and meta-analysis with trial sequential analysis
by: Chen-Wei Wu, et al.
Published: (2025-09-01)

Global Trends of Diabetic Erectile Dysfunction Research from 2012 to 2022: A Bibliometric and Visualized Study
by: Yohanes Andy Rias, et al.
Published: (2025-04-01)

Penile reinnervation as a new technique for treating erectile dysfunction in patients after radical prostatectomy
by: S. V. Popov, et al.
Published: (2020-12-01)

Assessing the influence of cardiovascular risk factors on the severity of erectile dysfunction: a multivariate statistical analysis
by: A. A. Kamalov, et al.
Published: (2022-04-01)

MODERN APPROACHES OF ERECTILE DYSFUNCTION DIAGNOSIS
by: P. V. Glybochko, et al.
Published: (2010-06-01)

RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES
by: E. V. Minakov, et al.
Published: (2016-01-01)

Meta-analysis of changes in erectile function in male renal failure patients after renal transplantation
by: Huang Jian-fang, et al.
Published: (2025-06-01)

Luteolin prevents fMLP-induced neutrophils adhesion via suppression of LFA-1 and phosphodiesterase 4 activity
by: Dai-xun JIANG, et al.
Published: (2015-01-01)

ASSOCIATION OF DEPRESSION AND ERECTILE DYSFUNCTION IN CARDIAC PATIENTS
by: S. A. Pomeshkina
Published: (2012-08-01)

Physiotherapy of chronic prostatitis complicated with erectile dysfunction
by: I. A. Kolmatsui, et al.
Published: (2012-04-01)

EXPERIENCE OF TOPIRAMATE CAPSULES TREATMENT OF CHILDREN
by: N. V. Freidkova
Published: (2016-08-01)

Modern views on erectile dysfunction and new methods for its treatment
by: A. L. Vertkin, et al.
Published: (2005-06-01)

Effect of endoscopic enucleation of the prostate on erectile and ejaculatory function
by: S. V. Kotov, et al.
Published: (2023-12-01)

Erectile function in patients after urethral plastic surgery
by: S. V. Kotov, et al.
Published: (2025-03-01)

Influence of gallic acid on porcine neutrophils phosphodiesterase 4, IL-6, TNF-α and rat arthritis model
by: Dai-xun JIANG, et al.
Published: (2015-04-01)

Effectiveness of the hypotension prediction index in non-cardiac surgeries: a systematic review, meta-analysis and trial sequential analysis
by: Vitor Alves Felippe, et al.
Published: (2025-09-01)

TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH VIBRATION DISEASE CAUSED BY EXPOSURE OF LOCAL VIBRATION
by: E. V. Katamanova, et al.
Published: (2012-09-01)

Disfunción sexual eréctil: ¿apenas una dificultad de los órganos sexuales?
by: Teresa Rodríguez Rodríguez
Published: (2017-07-01)

Could erectile dysfunction be a marker of atherosclerotic cardiovascular disease?
by: G. G. Sharvadze, et al.
Published: (1970-01-01)

HOW TO LINK ERECTILE DYSFUNCTION AND CHRONIC PELVIC PAIN SYNDROME
by: A. V. Shangichev, et al.
Published: (2013-06-01)

The inflatable penile prosthesis—the ultimate treatment for severe erectile dysfunction
by: Cristian Persu, et al.
Published: (2025-07-01)

Phosphodiesterase 10A as a Therapeutic Target in Neuropsychopharmacology: A Review
by: A. R. Dorotenko, et al.
Published: (2025-05-01)